Sepsis due to Methicillin resistant Staphylococcus aureus
ICD-10 A41.02 is a billable code used to indicate a diagnosis of sepsis due to methicillin resistant staphylococcus aureus.
Sepsis due to Methicillin-resistant Staphylococcus aureus (MRSA) is a severe systemic infection characterized by the presence of MRSA in the bloodstream, leading to a dysregulated immune response. MRSA is a strain of Staphylococcus aureus that has developed resistance to methicillin and other beta-lactam antibiotics, making it a significant cause of healthcare-associated infections. Patients with MRSA sepsis often present with symptoms such as fever, chills, tachycardia, and altered mental status. The condition can rapidly progress to septic shock, characterized by hypotension and multi-organ dysfunction, necessitating immediate medical intervention. Treatment typically involves the use of appropriate antibiotics, such as vancomycin or linezolid, and supportive care in an intensive care unit (ICU) setting. The management of MRSA sepsis requires careful monitoring of antibiotic susceptibility patterns and adherence to antimicrobial stewardship principles to prevent the development of further resistance. Early recognition and aggressive treatment are crucial for improving patient outcomes in this high-risk population.
Detailed microbiological results, treatment plans, and response to therapy.
Patients presenting with fever and suspected sepsis, requiring culture and sensitivity testing.
Documentation must clearly indicate the source of infection and any prior antibiotic use.
Comprehensive notes on hemodynamic status, organ function, and interventions.
Management of patients in the ICU with severe sepsis or septic shock.
Accurate recording of interventions and patient responses is crucial for coding severity.
Used for the initial evaluation and management of a patient with MRSA sepsis in the ICU.
Comprehensive history, examination, and medical decision-making details.
Critical care documentation must reflect the complexity of the patient's condition.
Coding A41.02 accurately reflects the presence of MRSA as the causative agent of sepsis, which is crucial for appropriate treatment and tracking of antibiotic resistance.
